Titan Bio-Tech [TITANBIO] vs Dishman Carbogen [DCAL] Detailed Stock Comparison

Titan Bio-Tech Ltd.

BSE
Loading...

Dishman Carbogen Amcis Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Titan Bio-Tech Ltd. wins in 8 metrics, Dishman Carbogen Amcis Ltd. wins in 10 metrics, with 0 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Titan Bio-Tech Ltd. Dishman Carbogen Amcis Ltd. Better
P/E Ratio (TTM) 74.64 22.30 Dishman Carbogen Amcis Ltd.
Price-to-Book Ratio 12.19 0.42 Dishman Carbogen Amcis Ltd.
Debt-to-Equity Ratio 5.32 40.20 Titan Bio-Tech Ltd.
PEG Ratio -1.22 -0.16 Dishman Carbogen Amcis Ltd.
EV/EBITDA 61.34 9.62 Dishman Carbogen Amcis Ltd.
Profit Margin (TTM) 14.13% 4.25% Titan Bio-Tech Ltd.
Operating Margin (TTM) 16.92% 3.99% Titan Bio-Tech Ltd.
EBITDA Margin (TTM) 16.92% 3.99% Titan Bio-Tech Ltd.
Return on Equity 14.04% 0.06% Titan Bio-Tech Ltd.
Return on Assets (TTM) 12.32% 0.03% Titan Bio-Tech Ltd.
Free Cash Flow (TTM) $106.79M $1.58B Dishman Carbogen Amcis Ltd.
Dividend Yield 0.42% N/A N/A
1-Year Return 419.45% -33.95% Titan Bio-Tech Ltd.
Price-to-Sales Ratio (TTM) 10.54 0.95 Dishman Carbogen Amcis Ltd.
Enterprise Value $20.35B $46.55B Dishman Carbogen Amcis Ltd.
EV/Revenue Ratio 10.57 1.66 Dishman Carbogen Amcis Ltd.
Gross Profit Margin (TTM) N/A 80.34% N/A
Revenue per Share (TTM) $47 $179 Dishman Carbogen Amcis Ltd.
Earnings per Share (Diluted) $6.58 $7.58 Dishman Carbogen Amcis Ltd.
Beta (Stock Volatility) -0.48 0.40 Titan Bio-Tech Ltd.

Titan Bio-Tech Ltd. vs Dishman Carbogen Amcis Ltd. Stock Performance Analysis

Loading Price Chart...

TITANBIO
DCAL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Titan Bio-Tech Ltd.0.80%3.09%-1.02%28.03%96.24%110.92%
Dishman Carbogen Amcis Ltd.-2.38%-2.24%-7.21%9.02%-19.76%-29.73%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Titan Bio-Tech Ltd.419.45%756.94%499.88%6,742.31%9,962.22%20,395.39%
Dishman Carbogen Amcis Ltd.-33.95%46.77%-6.77%33.46%290.77%118.12%

Performance & Financial Health Analysis: Titan Bio-Tech Ltd. vs Dishman Carbogen Amcis Ltd.

MetricTITANBIODCAL
Market Information
Market Cap i₹19.90B₹26.50B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i68,890337,264
90 Day Avg. Volume i156,601517,904
Last Close₹448.30₹180.24
52 Week Range₹74.73 - ₹555.65₹128.50 - ₹321.95
% from 52W High-19.32%-44.02%
All-Time High₹1,460.00 (Feb 18, 2026)₹396.40 (Jan 22, 2018)
% from All-Time High-69.29%-54.53%
Growth Metrics
Quarterly Revenue Growth0.48%0.06%
Quarterly Earnings Growth0.94%-0.09%
Financial Health
Profit Margin (TTM) i0.14%0.04%
Operating Margin (TTM) i0.17%0.04%
Return on Equity (TTM) i0.14%0.00%
Debt to Equity (MRQ) i5.3240.20
Cash & Liquidity
Book Value per Share (MRQ)₹40.29₹405.67
Cash per Share (MRQ)₹0.87₹40.41
Operating Cash Flow (TTM) i₹197.75M₹-199,700,000
Levered Free Cash Flow (TTM) i₹215.32M₹32.40M
Dividends
Last 12-Month Dividend Yield i0.42%N/A
Last 12-Month Dividend i₹4.00₹0.00

Valuation & Enterprise Metrics Analysis: Titan Bio-Tech Ltd. vs Dishman Carbogen Amcis Ltd.

MetricTITANBIO (Apr 24, 2026)DCAL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i74.6422.30
Forward P/E iN/A13.52
PEG Ratio i-1.22-0.16
Price to Sales (TTM) i10.540.95
Price to Book (MRQ) i12.190.42
Market Capitalization
Market Capitalization i₹19.90B₹26.50B
Enterprise Value i₹20.35B₹46.55B
Enterprise Value Metrics
Enterprise to Revenue i10.571.66
Enterprise to EBITDA i61.349.62
Risk & Other Metrics
Beta i-0.480.40
Book Value per Share (MRQ) i₹40.29₹405.67

Financial Statements Comparison: Titan Bio-Tech Ltd. vs Dishman Carbogen Amcis Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTITANBIO (2025)DCAL (2025)
Revenue/Sales i1.56B26.42B
Cost of Goods Sold i892.53M5.26B
COGS % of Revenue i57.0%19.9%
Gross Profit i671.98M21.16B
Gross Margin i43.0%80.1%
Research & Development iN/AN/A
Operating Income (EBIT) i212.57M1.46B
Operating Margin i13.6%5.5%
EBITDA i285.61M4.83B
EBITDA Margin i18.3%18.3%
Pre-Tax Income i243.67M193.10M
Pre-Tax Income % of Revenue i15.6%0.7%
Income Tax i60.96M160.70M
Income Tax % of Revenue i3.9%0.6%
Net Income (Profit) i215.32M32.40M
Profit Margin i13.8%0.1%

Balance Sheet & Liquidity Metrics

MetricTITANBIO (2025)DCAL (2025)
Cash & Equivalents i51.28M2.86B
Total Current Assets i790.38M22.00B
Total Current Assets % of Revenue i50.5%83.3%
Total Current Liabilities i177.36M19.25B
Total Current Liabilities % of Revenue i11.3%72.9%
Long-Term Debt i4.19M13.90B
Long-Term Debt % of Revenue i0.3%52.6%
Total Shareholders Equity i1.53B58.32B
Retained Earnings i1.36B2.13B
Retained Earnings % of Revenue i87.0%8.1%
Property, Plant & Equipment i571.62M10.27B

Cash Flow Statement Comparison

MetricTITANBIO (2025)DCAL (2025)
Operating Cash Flow i197.75M-199.70M
Operating Cash Flow % of Revenue i12.6%-0.8%
Capital Expenditures i-85.26M-2.15B
Free Cash Flow i106.79M1.58B
FCF Margin i6.8%6.0%
Debt Repayment i-2.69M-1.10B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTITANBIODCAL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i41.32M156.78M
Float Shares i13.13M54.95M
% Held by Insiders i68.21%69.30%
% Held by Institutions i0.00%2.41%
% Held by Public i31.79%28.29%

Dividend Analysis & Yield Comparison: Titan Bio-Tech Ltd. vs Dishman Carbogen Amcis Ltd.

MetricTITANBIODCAL
Last 12-Month Dividend i₹4.00₹0.00
Last 12-Month Dividend Yield i0.42%N/A
3-Year Avg Annual Dividend i₹1.93₹0.00
3-Year Avg Dividend Yield i0.34%N/A
3-Year Total Dividends i₹5.80₹0.00
Ex-Dividend DateSep 19, 2025N/A